Lance Stapleton is an experienced scientist with a robust background in biological research and immunology. Currently serving as a Senior Associate Scientist at Gilead Sciences since March 2016, Lance previously held roles at Compugen Inc. and Novartis, focusing on immuno-oncology and biological therapeutics, respectively. Notable contributions include decision-driving research on biological markers for antibody-based therapeutics and optimization of validation protocols. Earlier experience at UCSF involved NIH-funded research on small molecule inhibitors targeting cancer growth, while initial work as a Laboratory Technician at Davis Sequencing LLC involved high-throughput PCR processing. Lance holds a Master of Science in Biology from the University of San Francisco and a Bachelor of Science in Genetics from the University of California, Davis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices